A detailed history of Barclays PLC transactions in Davita Inc. stock. As of the latest transaction made, Barclays PLC holds 194,932 shares of DVA stock, worth $29.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
194,932
Previous 194,932 -0.0%
Holding current value
$29.6 Million
Previous $32 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$133.98 - $165.19 $1.82 Million - $2.25 Million
-13,621 Reduced 6.53%
194,932 $32 Million
Q2 2024

Aug 14, 2024

SELL
$126.11 - $147.14 $5.17 Million - $6.03 Million
-40,966 Reduced 16.42%
208,553 $28.9 Million
Q1 2024

May 15, 2024

SELL
$103.89 - $139.21 $2.19 Million - $2.94 Million
-21,092 Reduced 7.79%
249,519 $34.4 Million
Q4 2023

Feb 15, 2024

BUY
$73.2 - $108.8 $7.81 Million - $11.6 Million
106,750 Added 65.15%
270,611 $28.3 Million
Q3 2023

Nov 07, 2023

BUY
$94.53 - $112.68 $1.09 Million - $1.29 Million
11,488 Added 7.54%
163,861 $15.5 Million
Q2 2023

Aug 03, 2023

BUY
$81.58 - $100.93 $3.74 Million - $4.63 Million
45,832 Added 43.02%
152,373 $15.3 Million
Q1 2023

May 04, 2023

BUY
$74.68 - $85.82 $344,722 - $396,145
4,616 Added 4.53%
106,541 $8.64 Million
Q4 2022

Feb 13, 2023

SELL
$65.42 - $99.31 $117,886 - $178,956
-1,802 Reduced 1.74%
101,925 $7.61 Million
Q3 2022

Nov 03, 2022

SELL
$80.24 - $95.27 $5.53 Million - $6.56 Million
-68,900 Reduced 39.91%
103,727 $8.58 Million
Q2 2022

Aug 12, 2022

BUY
$76.05 - $123.38 $5.86 Million - $9.5 Million
76,990 Added 80.5%
172,627 $13.8 Million
Q1 2022

May 16, 2022

SELL
$108.37 - $120.0 $15.3 Million - $16.9 Million
-141,121 Reduced 59.61%
95,637 $10.8 Million
Q4 2021

Feb 14, 2022

BUY
$94.5 - $116.95 $798,619 - $988,344
8,451 Added 3.7%
236,758 $26.9 Million
Q3 2021

Nov 09, 2021

BUY
$116.26 - $133.78 $4.69 Million - $5.4 Million
40,382 Added 21.49%
228,307 $26.5 Million
Q2 2021

Aug 13, 2021

SELL
$105.44 - $127.98 $2.8 Million - $3.4 Million
-26,595 Reduced 12.4%
187,925 $22.6 Million
Q1 2021

May 13, 2021

BUY
$99.98 - $123.89 $158,468 - $196,365
1,585 Added 0.74%
214,520 $23.1 Million
Q4 2020

Feb 11, 2021

BUY
$82.82 - $117.4 $500,729 - $709,800
6,046 Added 2.92%
212,935 $25 Million
Q3 2020

Nov 12, 2020

BUY
$79.57 - $91.84 $1.53 Million - $1.76 Million
19,212 Added 10.24%
206,889 $17.7 Million
Q2 2020

Aug 12, 2020

BUY
$65.52 - $88.28 $331,465 - $446,608
5,059 Added 2.77%
187,677 $14.9 Million
Q1 2020

May 13, 2020

SELL
$64.99 - $88.5 $7.63 Million - $10.4 Million
-117,396 Reduced 39.13%
182,618 $13.9 Million
Q4 2019

Feb 10, 2020

BUY
$54.2 - $75.03 $7.15 Million - $9.89 Million
131,871 Added 78.43%
300,014 $22.5 Million
Q3 2019

Nov 14, 2019

SELL
$52.55 - $63.28 $732,126 - $881,616
-13,932 Reduced 7.65%
168,143 $9.6 Million
Q2 2019

Aug 14, 2019

SELL
$43.42 - $57.79 $13 Million - $17.3 Million
-299,866 Reduced 62.22%
182,075 $10.2 Million
Q1 2019

May 15, 2019

BUY
$49.95 - $59.21 $14.9 Million - $17.7 Million
299,048 Added 163.51%
481,941 $26.2 Million
Q4 2018

Feb 14, 2019

SELL
$48.73 - $76.08 $12.6 Million - $19.6 Million
-257,709 Reduced 58.49%
182,893 $9.41 Million
Q3 2018

Nov 14, 2018

SELL
$66.51 - $74.55 $1.51 Million - $1.69 Million
-22,708 Reduced 4.9%
440,602 $31.6 Million
Q2 2018

Aug 14, 2018

SELL
$62.77 - $73.47 $2.35 Million - $2.75 Million
-37,467 Reduced 7.48%
463,310 $32.2 Million
Q1 2018

May 15, 2018

BUY
$65.0 - $80.03 $11.8 Million - $14.6 Million
181,921 Added 57.05%
500,777 $33 Million
Q4 2017

Feb 14, 2018

BUY
$53.89 - $72.36 $9.26 Million - $12.4 Million
171,769 Added 116.78%
318,856 $23 Million
Q3 2017

Nov 14, 2017

BUY
$56.13 - $64.78 $8.26 Million - $9.53 Million
147,087
147,087 $8.74 Million

Others Institutions Holding DVA

About DAVITA INC.


  • Ticker DVA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 91,300,000
  • Market Cap $13.9B
  • Description
  • DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...
More about DVA
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.